AN alternative to Botox, Xeomin,
has been approved by the US Food
and Drug Administration to treat
severe frown lines or 11’s between
the eyebrows.
Manufactured by Merz
Aesthetics, Xeoman is different
from Botox in that it has no other
additives other than botulinum
toxin type A to block the signals
from the nerves to the muscles.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Nov 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Nov 11
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.